List of Attending Speakers | 2023
- Steven Bartz, Vice President Corporate Development, Seagen
- Alex Burgin, Director of the Center for the Development of Therapeutics, Broad Institute of MIT and Harvard
- Lisa Carnell, Program Scientist for Translational Research, NASA
- Steven Chinowsky, Partner, Latham & Watkins
- Twyman Clements, Co-Founder & CEO, Space Tango+
- John Connolly, Chief Scientific Officer, Parker Institute for Cancer Immunology
- Niels Emmerich, VP Global Head, Search & Evaluation, AbbVie
- Kevin Engelbert, International Space Station Program – Economic & Business Development Office, NASA
- Dan Estes, General Partner, Frazier Healthcare Partners
- Jason Fenton, Managing Director, Equity Capital Markets, Oppenheimer & Co.
- Angus Grant, Chief Business Executive, BeiGene
- David Greenwald, Vice President, Business Development, Deerfield Management
- Jason Hafler, Managing Director, Sanofi Ventures
- Nancy Hong, Managing Director, RiverVest
- John Hood, Co-Founder and CEO, Endeavor Biomedicines
- Lila Hope, Partner, Cooley
- Catriona Jamieson, MD, PhD, Director, Sanford Stem Cell Institute, UC San Diego
- Ash Khanna, Partner, Pivotal bioVenture Partners
- Rachna Khosla, Senior Vice President, Business Development, Amgen
- Nina Kjellson, General Partner, Canaan Partners
- Jim Krenn, Partner, Morrison Foerster
- Angela Kujak, Head of Legal Office of Strategic Alliances and Partnerships, Broad Institute
- Jennifer Leeds, Executive Director, Head NIBR BD&L Search and Evaluation, West Coast and Canada, Novartis
- Jay Lichter, Managing Director, Avalon Ventures; President and CEO, Arialys Therapeutics
- Tim Luker, Vice President, Venture Science, West Coast USA Head, Corp BD, Eli Lilly
- Christian Maender, Executive Vice President, In-Space Solutions, Axiom Space
- Patty Maysent, CEO, UC San Diego Health
- Grace Han McMahon, Associate Vice President and Head, Pacific BD&L, Merck
- Detlev Mennerich, Corporate SVP, Global Head of Business Development & Licensing, Boehringer Ingelheim
- Imran Nassrullah, VP & Head, Collaborate2Cure, Hub, US, BD&L, Merck
- Vern Norviel, Partner, Patents and Innovation, Wilson Sonsini
- Carole Nuechterlein, Head, Roche Venture Fund
- Michael Palladinetti, Global Head of Business Development & Licensing, Sanofi
- Joe Panetta, President and CEO, Biocom California
- Mark Paris, Executive Director, Oncology Search and Evaluation, Daiichi Sankyo, Inc
- Scott Platshon, Partner, EcoR1
- Jeremy Quirk, VP BD&L Commercial Portfolio, GSK
- Visali Ramanathan, Senior Director, Business Development, Genentech
- John Reed, Designate Global Head of R&D, Johnson & Johnson
- Alicia Russo, Partner, Venable
- Camille Samuels, Partner, Venrock
- Andy Schwab, Founder and Managing Partner, 5AM Ventures
- Arun Sharma, PhD, Assistant Professor, Board of Governors, Regenerative Medicine Institute, Smidt Heart Institute, Cedars-Sinai
- Ken Shields, Sr. Director, Business Development, Sierra Space
- Deborah Smith, Partner, Wilson Sonsini
- Tari Suprapto, Director, Search & Evaluation (West), Novo Nordisk
- Matt Tremblay, COO, Scripps Research Institute and Calibr
- Issei Tsukamoto, SVP, Head of Business Development, Astellas Pharma
- Daniel Tumas, VP, Head of Search and Evaluation, Gilead Sciences
- Court Turner, Partner at LYZZ Capital Advisors
- D.A. Wallach, General Partner, Co-Founder, Time BioVentures
- Asish Xavier, Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC